Transaction | Address | Amount |
---|---|---|
b94050...b2f03a
|
the-void |
-
6.31494179 LTC
·
534.68 USD
|
b94050...b2f03a
|
LcNS6c...osnkN3
|
+
6.31494179 LTC
·
534.68 USD
|
b94050...b2f03a
|
script-6568dcf8c62b136d775d03b1f6766f24 |
+
0 LTC
·
0.00 USD
|
7babfa...193ce0
|
LYUrQX...r227A8
|
-
51.09525671 LTC
·
4,326.23 USD
|
7babfa...193ce0
|
MLvsgz...oRwdvm
|
+
0.52189394 LTC
·
44.18 USD
|
7babfa...193ce0
|
MH2auL...ooiqfg
|
+
1.42593585 LTC
·
120.73 USD
|
7babfa...193ce0
|
LYQmsd...njq5Jz
|
+
49.14142692 LTC
·
4,160.80 USD
|
7babfa...193ce0
|
the-void |
+
0.006 LTC
·
0.50 USD
|
4de4d0...de985d
|
ltc1q7...sc7glc
|
-
0.37805407 LTC
·
32.00 USD
|
4de4d0...de985d
|
LX4Bbu...LPKGrA
|
+
0.225973 LTC
·
19.13 USD
|
Exploring DeSoc's potential for higher returns compared to Litecoin, Monero, and AVAX.
As July ends, investors debate whether DeSoc, Litecoin, or XRP offers the best investment potential. Litecoin surged with a $100 million move by MEI Pharma, while XRP's rise is fueled by new institutional confidence.
DeSoc’s presale exceeds $10 million, aiming to challenge Dogecoin and Litecoin with a user-rewarding social platform.